Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Inhibitors of the fibrinolytic enzyme system.

× No keyword cloud information.

16 in total

Review 1. Streptokinase--the drug of choice for thrombolytic therapy.

Authors: Adinarayana Kunamneni; Thaer Taleb Abed Abdelghani; Poluri Ellaiah
Journal: J Thromb Thrombolysis Date: 2007-02 Impact factor: 2.300

2. Kinetics of the reaction of streptokinase-plasmin complex with purified human and mouse alpha 2-macroglobulin. Implications for mechanism.

Authors: P K Anonick; W H Vetter; S L Gonias
Journal: Biochem J Date: 1989-12-15 Impact factor: 3.857

3. Alpha 2-macroglobulin is the primary inhibitor of miniplasmin in vitro and in vivo in the mouse. Comparison with alpha 2-antiplasmin in simultaneous reaction experiments.

Authors: S L Gonias; N L Figler
Journal: Biochem J Date: 1988-10-15 Impact factor: 3.857

4. Organization of the human alpha 2-plasmin inhibitor gene.

Authors: S Hirosawa; Y Nakamura; O Miura; Y Sumi; N Aoki
Journal: Proc Natl Acad Sci U S A Date: 1988-09 Impact factor: 11.205

Review 5. Trends and future developments in the pharmacological treatment of acute ischaemic stroke.

Authors: G J del Zoppo; S Wagner; M Tagaya
Journal: Drugs Date: 1997-07 Impact factor: 9.546

6. Different N-terminal forms of alpha 2-plasmin inhibitor in human plasma.

Authors: K Bangert; A H Johnsen; U Christensen; S Thorsen
Journal: Biochem J Date: 1993-04-15 Impact factor: 3.857

7. Alpha 2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysis.

Authors: J I Weitz; B Leslie; J Hirsh; P Klement
Journal: J Clin Invest Date: 1993-04 Impact factor: 14.808

8. Evidence that alpha2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation.

Authors: M W Mosesson; K R Siebenlist; I Hernandez; K N Lee; V J Christiansen; P A McKee
Journal: J Thromb Haemost Date: 2008-06-16 Impact factor: 5.824

Review 9. Thrombolytic therapy in the treatment of stroke.

Authors: G J del Zoppo
Journal: Drugs Date: 1997 Impact factor: 9.546

10. Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis.

Authors: J Mimuro; S Kimura; N Aoki
Journal: J Clin Invest Date: 1986-03 Impact factor: 14.808